Lexaria Bioscience Corp. (LEXXW) NASDAQ

0.04

+0.0001(+0.28%)

Updated at October 21 04:00PM

Currency In USD

Valuation

Market Cap48.42M
Enterprise Value42.06M
P/E Ratio-1.46
PEG Ratio0.11
Price/Sales Ratio28.85
Price/Book Ratio2.99
Enterprise/Revenue21.59
Enterprise/EBITDA-1.17

Fiscal Year

Fiscal YearAugust 31, 2024
Most Recent QuarterMay 31, 2025

Profitability

Profit Margin-18.49
Operating Margin-18.5

Management Effectiveness

Return On Assets-1.69
Return On Equity-1.49

Income Statement

Revenue464,278
Revenue/Share0.03
Gross Profit459,456
EBITDA-5.68M
Net Income-5.8M
Diluted EPS-0.47

Balance Sheet

Total Cash4.63M
Total Cash/Share0.25
Total Debt116,586
Total Debt/Equity0.02
Current Ratio3.9
Book Value Per Share0.28

Price History

52-Week Change-95.59
52-Week High0.04
52-Week Low0.04
Moving Average 50 Days0.09
Moving Average 200 Days0.35

Statistics

Average Volume8,652.78
Shares Outstanding116.62M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A